Urine biomarkers of pulmonary tuberculosis

References

• Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO
   Google Scholar
• Drobniewski F, Nikolayevskyy V, Maxeiner H, et al. Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation. BMC Med. 2013; 11. 1741-7015 doi:https://doi.org/10.1186/1741-7015-11-190
   Google Scholar
• High priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting, 28–29 April 2014, Geneva Switzerland, WHO/HTM/TB/2014.18 [https://apps.who.int/iris/handle/10665/135617]
   Google Scholar
• World Health Organization. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV. Policy update 2019. Geneva:World Health Organization. 2019. Licence: CC BY-NC-SA 3.0 IGO
   Google Scholar
• MacLean E, Broger T, Yerlikaya S, et al. A systematic review of biomarkers to detect active tuberculosis. Nat Microbiol. 2019;4(5):748–758.
   PubMed Web of Science ®Google Scholar
• Fernández-Carballo BL, Broger T, Wyss R, et al. Toward the development of a circulating free DNA-based in vitro diagnostic test for infectious diseases: review of evidence for tuberculosis. J Clin Microbiol. 2019;57(4):e01234–18.
   PubMed Web of Science ®Google Scholar
• Oreskovic A, Brault ND, Panpradist N, et al. Analytical comparison of methods for extraction of short cell-free DNA from urine. J Mol Diagn. 2019;21(6):1067–1078.
   PubMedGoogle Scholar
• Bordelon H, Russ PK, Wright DW, et al. A magnetic bead-based method for concentrating DNA from human urine for downstream detection. PLoS One. 2013;8(7):e68369.
   PubMed Web of Science ®Google Scholar
• Bordelon H, Ricks KM, Pask ME, et al. Design and use of mouse control DNA for DNA biomarker extraction and PCR detection from urine: application for transrenal Mycobacterium tuberculosis DNA detection. J Microbiol Methods. 2017;136:65–70.
   PubMedGoogle Scholar
• Patel K, Nagel M, Wesolowski M, et al. Evaluation of a urine-based rapid molecular diagnostic test with potential to be used at point-of-care for pulmonary tuberculosis: cape town cohort. J Mol Diagn. 2018;20(2):215–224.
   PubMed Web of Science ®Google Scholar
• Sinkov VV, Ogarkov OB, Plotnikov AO, et al. Metagenomic analysis of mycobacterial transrenal DNA in patients with HIV and tuberculosis coinfection. Infect Genet Evol. 2020;77:104057.
   PubMedGoogle Scholar
• Oreskovic A, Panpradist N, Marangu D, et al. Diagnosing pulmonary tuberculosis by using sequence-specific purification of urine cell-free DNA. J Clin Microbiol. 2021 Jul 19;59(8):e0007421.
   PubMed Web of Science ®Google Scholar
• Oreskovic A, Waalkes A, Holmes EA, et al. Characterizing the molecular composition and diagnostic potential of Mycobacterium tuberculosis urinary cell-free DNA using next-generation sequencing. Int J Infect Dis. 2021 Nov;112:330–337.
   PubMedGoogle Scholar
• Hayney MS, Henriquez M, Barnet JH, et al. Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults. J Clin Virol. 2017. 1386-6532;90:32–37.
   PubMedGoogle Scholar
• Kim SY, Kim J, Kim DR, et al. Urine IP-10 as a biomarker of therapeutic response in patients with active pulmonary tuberculosis. BMC Infect Dis. 2018;18(1):240.
   PubMedGoogle Scholar
• Petrone L, Cannas A, Vanini V, et al. Blood and urine inducible protein 10 as potential markers of disease activity. Int J Tuberc Lung Dis. 2016;20(11):1554–1561.
   PubMed Web of Science ®Google Scholar
• Petrone L, Cannas A, Aloi F, et al. Blood or urine IP-10 cannot discriminate between active tuberculosis and respiratory diseases different from tuberculosis in children. Biomed Res Int. 2015;2015:589471.
   PubMed Web of Science ®Google Scholar
• Cannas A, Calvo L, Chiacchio T, et al. IP-10 detection in urine is associated with lung diseases. BMC Infect Dis. 2010;10:333.
   PubMed Web of Science ®Google Scholar
• Fortún J, Martín-Dávila P, Gómez-Mampaso E, et al. Extra-pulmonary tuberculosis: differential aspects and role of 16S-rRNA in urine. Int J Tuberc Lung Dis. 2014;18(4):478–485.
   PubMedGoogle Scholar
• Cubero N, Esteban J, Palenque E, et al. Evaluation of the detection of Mycobacterium tuberculosis with metabolic activity in culture-negative human clinical samples. Clin Microbiol Infect. 2013;19(3):273–278.
   PubMed Web of Science ®Google Scholar
• Isa F, Collins S, Lee MH, et al. Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis. EBioMedicine. 2018;31:157–165*.
   PubMed Web of Science ®Google Scholar
• Deng J, Liu L, Yang Q, et al. Urinary metabolomic analysis to identify potential markers for the diagnosis of tuberculosis and latent tuberculosis. Arch Biochem Biophys. 2021 Jun 15;704:108876.
   PubMedGoogle Scholar
• Russell TM, Green LS, Rice T, et al. Potential of high-affinity, slow off-rate modified aptamer reagents for mycobacterium tuberculosis proteins as tools for infection models and diagnostic applications. J Clin Microbiol. 2017;55(10):3072–3088.
   PubMed Web of Science ®Google Scholar
• Dang NA, Janssen HG, Kolk AH. Rapid diagnosis of TB using GC-MS and chemometrics. Bioanalysis. 2013;5(24):3079–3097.
   PubMedGoogle Scholar
• Sandlund J, Lim S, Queralto N, et al. Development of colorimetric sensor array for diagnosis of tuberculosis through detection of urinary volatile organic compounds. Diagn Microbiol Infect Dis. 2018;92(4):299–304.
   PubMedGoogle Scholar
• Pollock NR, Macovei L, Kanunfre K, et al. Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis. J Clin Microbiol. 2013;51(5):1367–1373.
   PubMedGoogle Scholar
• Kim SH, Lee NE, Lee JS, et al. Identification of mycobacterial antigens in human urine by use of immunoglobulin G isolated from sera of patients with active pulmonary tuberculosis. J Clin Microbiol. 2016;54(6):1631–1637.
   PubMedGoogle Scholar
• Eribo OA, Leqheka MS, Malherbe ST, et al. Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis. Int J Infect Dis. 2020;99:473–481.
   PubMedGoogle Scholar
• Pollock N, Dhiman R, Daifalla N, et al. Discovery of a unique Mycobacterium tuberculosis protein through proteomic analysis of urine from patients with active tuberculosis. Microbes Infect. 2018;20(4):228–235.
   PubMed Web of Science ®Google Scholar
• Liu L, Deng J, Yang Q, et al. Urinary proteomic analysis to identify a potential protein biomarker panel for the diagnosis of tuberculosis. IUBMB Life. 2021 Aug;73(8):1073–1083.
   PubMed Web of Science ®Google Scholar
• Das MK, Bishwal SC, Das A, et al. Deregulated tyrosine-phenylalanine metabolism in pulmonary tuberculosis patients. J Proteome Res. 2015;14(4):1947–1956*.
   PubMed Web of Science ®Google Scholar
• Fitzgerald BL, Mahapatra S, Farmer DK, et al. Elucidating the structure of N1-acetylisoputreanine: a novel polyamine catabolite in human urine. ACS Omega. 2017;2(7):3921–3930.
   PubMedGoogle Scholar
• Xia Q, Lee MH, Rhee KY, et al. N1, N12-diacetylspermine as potential urinary biomarker to monitor treatment response and bacterial load in pulmonary tuberculosis. Open Forum Infect Dis. 2019;6(Suppl 2):S53.
   Google Scholar
• Xia Q, Lee MH, Walsh KF, et al. Urinary biomarkers of mycobacterial load and treatment response in pulmonary tuberculosis. JCI Insight. 2020;5(18):e136301.
   PubMedGoogle Scholar
• Fitzgerald BL, Islam MN, Graham B, et al. Correction to “Elucidation of a novel human urine metabolite as a seryl-leucine glycopeptide and as a biomarker of effective anti-tuberculosis therapy”. ACS Infect Dis. 2019;5(6):1042–1043.
   PubMedGoogle Scholar
• Combrink M, du Preez I, Ronacher K, et al. Time-dependent changes in urinary metabolome before and after intensive phase tuberculosis therapy: a pharmacometabolomics study. OMICS. 2019;23(11):560–572.
   PubMedGoogle Scholar
• Mahapatra S, Hess AM, Johnson JL, et al. A metabolic biosignature of early response to anti-tuberculosis treatment. BMC Infect Dis. 2014;14(1):53.
   PubMedGoogle Scholar
• Luies L, Reenen M, Ronacher K, et al. Predicting tuberculosis treatment outcome using metabolomics. Biomark Med. 2017;11(12):1057–1067.
   PubMedGoogle Scholar